VALERITAS
Valeritas is a medical technology company committed to developing and commercializing innovative drug delivery solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of diabetes. Valeritas' medical technologies portfolio is headlined by the h-Patch technology. The first use of the h-Patch technology will be the V-Go disposable insulin delivery device for continuous delivery both at a preset basal rate and for on-demand bolus dosing ... at mealtimes. The V-Go is a simple-to-use, once-daily, disposable insulin delivery device that provides a preset basal rate and on-demand bolus dosing for mealtime coverage via a mealtime insulin. The V-Go will enable the millions suffering from Type 2 diabetes to conveniently and discreetly deliver insulin throughout the day bolus dose on-demand around mealtimes. The h-Patch technology is also being developed to serve as a launching platform for applications across a wide spectrum of medical needs.
VALERITAS
Industry:
Biotechnology Diabetes Health Care Medical Device
Founded:
2006-01-01
Address:
Bridgewater, New Jersey, United States
Country:
United States
Website Url:
http://www.valeritas.com
Total Employee:
51+
Status:
Closed
Contact:
908-927-9920
Email Addresses:
[email protected]
Total Funding:
355 M USD
Technology used in webpage:
Domain Not Resolving Content Delivery Network Amazon GoDaddy DNS AWS Global Accelerator Verizon Verizon FIOS
Similar Organizations
Cnoga Medical
Cnoga Medical empowers people with easy-to-use, non-invasive medical devices.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Bolder Surgical
Bolder Surgical serves health care providers by developing surgical instruments that allow access to confined and delicate structures.
PECA Labs
PECA Labs is dedicated to bringing better medical devices to orphan populations, with initial focus on the pediatric cardiovascular system.
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CRG
CRG investment in Venture Round - Valeritas
Montrose Capital Partners
Montrose Capital Partners investment in Venture Round - Valeritas
Welsh Carson Anderson & Stowe
Welsh Carson Anderson & Stowe investment in Series D - Valeritas
Advanced Technology Ventures
Advanced Technology Ventures investment in Series D - Valeritas
Kaiser Permanente Ventures
Kaiser Permanente Ventures investment in Series D - Valeritas
Abingworth
Abingworth investment in Series D - Valeritas
Pitango VC
Pitango VC investment in Series D - Valeritas
MPM Capital
MPM Capital investment in Series D - Valeritas
ONSET Ventures
ONSET Ventures investment in Series D - Valeritas
CRG
CRG investment in Debt Financing - Valeritas
Official Site Inspections
http://www.valeritas.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Valeritas"
Valeritas - Crunchbase Company Profile & Funding
Valeritas is a medical technology company committed to developing and commercializing innovative drug delivery solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of …See details»
Valeritas - Leadership Team - The Org
The Leadership Team at Valeritas is responsible for setting strategic direction, fostering innovation, and ensuring operational excellence to effectively enhance the health and quality …See details»
Valeritas Company Profile - Office Locations, Competitors …
Aug 13, 2020 · Valeritas is a medical technology company developing solutions for people with diabetes. It offers a V-Go wearable insulin delivery device (V-Go) for the delivery of basal …See details»
Valeritas Holdings Company Profile 2024: …
Operator of a medical technology company intended to improve health and simplifying life for people with diabetes. The company is engaged in the business of developing and commercializing innovative technologies to improve the …See details»
Valeritas - LinkedIn
We are a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies.See details»
Valeritas - Products, Competitors, Financials, Employees, …
Valeritas is committed to developing and commercializing treatment solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of Type 2 …See details»
Valeritas - Contacts, Employees, Board Members, Advisors …
Valeritas is the developer of V-GO, a disposable insulin pump, and a micro needle patch for the treatment of Type 2 diabetes.See details»
Robert R. Gonnelli - Founder & CEO @ Valeritas
Robert R. Gonnelli is the founder and the chief executive officer of Valeritas, the developer of V-GO, a disposable insulin pump, and a micro needle patch for the treatment of Type 2 diabetes. …See details»
Valeritas - VentureRadar
Valeritas is a medical technology company committed to the development and commercialization of innovative drug delivery solutions that contribute to clinical and humanistic outcomes for …See details»
Valeritas CEO and Key Executive Team | Craft.co
Valeritas's President and Chief Executive Officer is Emmanuel Dulac. Other executives include Matt Dallas, Senior Vice President and Chief Financial Officer; Adam Steensberg, Executive …See details»
Zealand Pharma completes the acquisition of Valeritas
Feb 4, 2020 · V-Go is a simple, affordable, all-in-one basal-bolus insulin delivery device for adult patients requiring insulin that is worn like a patch and can eliminate the need for taking …See details»
Valeritas | EquityNet
Valeritas is a medical technology company committed to developing and commercializing innovative drug delivery solutions that contribute to clinical and humanistic outcomes for …See details»
Zealand Pharma announces bid to acquire Valeritas
Feb 10, 2020 · Valeritas is a U.S.-based commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes.See details»
Valeritas - Crunchbase
Valeritas is the developer of V-GO, a disposable insulin pump, and a micro needle patch for the treatment of Type 2 diabetes.See details»
Valeritas Careers and Employment | Indeed.com
Feb 10, 2023 · Find out what works well at Valeritas from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular …See details»
Kristine Peterson - Paratek Pharma
In her previous role as Chief Executive Officer at Valeritas, Inc., from June 2009 to February 2016, she evolved the organization from an early-stage company to a fully commercial …See details»
Medical Device Maker Valeritas Gets Bankruptcy Plan …
Jun 4, 2020 · Medical device developer Valeritas Holdings Inc. received approval to exit bankruptcy under a plan centered around a $23 million sale of the company.See details»
Valeritas - Funding, Financials, Valuation & Investors
Valeritas is the developer of V-GO, a disposable insulin pump, and a micro needle patch for the treatment of Type 2 diabetes.See details»
Insulin pump maker Valeritas files for bankruptcy amid …
Feb 10, 2020 · Long-troubled Valeritas, manufacturers of a wearable, disposable insulin pump, has filed for Chapter 11 bankruptcy as part of a plan to hand off its business to the specialty …See details»
Bankrupt Valeritas' $23 Million Sale, Linked Settlement …
Mar 20, 2020 · Medical device company Valeritas Holdings Inc. won court approval of its $23 million sale and a settlement with key stakeholders, drawing a road map for exiting a …See details»